# Colorectal Polyps and Early Neoplasia

## Overview

Colorectal polyps are the most common neoplastic precursors encountered in GI pathology. Understanding both the conventional adenoma-carcinoma sequence and the serrated neoplasia pathway is essential for accurate classification and risk stratification. Polyp type, size, number, and grade of dysplasia together determine surveillance intervals and management decisions.

## Conventional Adenomas

### General Features

Conventional adenomas are true neoplastic polyps arising through the chromosomal instability (CIN) pathway. The initiating event in the adenoma-carcinoma sequence (the Vogelstein model) is an APC mutation, followed by subsequent mutations in KRAS, TP53, SMAD4, and loss of heterozygosity at 18q. The risk of malignant transformation correlates with polyp size, proportion of villous architecture, and grade of dysplasia.

### Histologic Subtypes

| Subtype | Frequency | Villous Component | Malignant Transformation Risk |
|---|---|---|---|
| Tubular adenoma | ~80% | <25% | ~5% |
| Tubulovillous adenoma | 10–15% | 25–75% | ~20% |
| Villous adenoma | 5–10% | >75% | ~40% (large lesions) |

#### Tubular Adenoma

Tubular adenomas are the most common type, accounting for approximately 80 percent of all adenomas. They have greater than 75 percent tubular architecture (round to oval glands) and harbor low-grade dysplasia in most cases. The overall malignant transformation risk is approximately 5 percent.

#### Tubulovillous Adenoma

Tubulovillous adenomas contain 25 to 75 percent villous component (finger-like projections) and carry intermediate risk. They account for 10 to 15 percent of adenomas with a malignant transformation risk of approximately 20 percent.

#### Villous Adenoma

Villous adenomas have greater than 75 percent villous architecture. They tend to be large and sessile with a rectal predilection and carry the highest risk of harboring carcinoma (approximately 40 percent in large lesions). Rarely, they may cause secretory diarrhea with hypokalemia.

### Dysplasia Grading

Low-grade dysplasia features pseudostratified, elongated, pencillate hyperchromatic nuclei confined to the lower half to two-thirds of the epithelium with maintained polarity. High-grade dysplasia shows marked nuclear atypia, loss of polarity, nuclei reaching the luminal surface, cribriform architecture, back-to-back glands, and architectural complexity, all without invasion through the muscularis mucosae.

## Serrated Polyps

### The Serrated Pathway

The serrated pathway represents an alternative route to colorectal cancer, accounting for 20 to 30 percent of all colorectal carcinomas. Its key molecular features include BRAF V600E mutation, CpG island methylator phenotype (CIMP), and MLH1 promoter hypermethylation leading to microsatellite instability-high (MSI-H) status. This pathway is responsible for most interval cancers (cancers detected between scheduled screening colonoscopies).

### Hyperplastic Polyp (HP)

Hyperplastic polyps are the most common serrated polyp and the most common polyp overall. They are typically small (less than 5 mm) and located in the distal colon or rectum. Histologically, they show a serrated (saw-tooth) luminal profile in the upper crypt with a normal-appearing base without distortion. Nuclei are narrow and pencillate at the base, with maturation toward the surface. Subtypes include microvesicular (MVHP, which is BRAF-mutated), goblet cell-rich (GCHP, which is KRAS-mutated), and mucin-poor. The microvesicular subtype may be a precursor to sessile serrated lesions. When small and distal, hyperplastic polyps have no surveillance implications.

### Sessile Serrated Lesion (SSL) / Sessile Serrated Polyp

Previously known as sessile serrated adenoma/polyp (SSA/P), this is the key precursor lesion in the serrated pathway. SSLs have a proximal colon predilection, flat or sessile morphology, and are often subtle endoscopically.

#### Diagnostic Criteria (WHO 5th Edition)

The diagnosis requires one or more of the following architectural features: serration extending to the crypt base, dilated crypt bases (boot-shaped, L-shaped, inverted T-shaped, or anchor-shaped crypts), horizontal growth of crypt bases along the muscularis mucosae, or asymmetric proliferation (displaced proliferative zone). These features distinguish SSLs from hyperplastic polyps. No cytologic dysplasia is required for the diagnosis.

#### SSL with Dysplasia

When cytologic dysplasia develops within an SSL, it indicates progression toward carcinoma. "Conventional" dysplasia appears as intestinal-type adenomatous epithelium arising within the SSL. "Serrated" dysplasia shows atypical cuboidal or eosinophilic cells with maintained serrated architecture, often with gastric-type features. SSL with dysplasia carries increased risk of rapid progression to carcinoma, making complete excision essential.

### Traditional Serrated Adenoma (TSA)

The TSA is the least common serrated polyp (approximately 1 percent). It has a left colon predilection and is often pedunculated or protuberant. Its distinctive morphology features eosinophilic, pencil-shaped cells with centrally placed elongated nuclei and slit-like serration. The most specific diagnostic feature is ectopic crypt foci (ECF), which are small crypts budding laterally from the main crypts. Molecularly, TSAs harbor KRAS or BRAF mutations, and some are CIMP-positive. They have malignant potential and require complete excision.

## Malignant Polyps (Polyp Cancers)

### Definition

A malignant polyp is defined as adenocarcinoma invading through the muscularis mucosae into the submucosa (pT1). Intramucosal carcinoma (invasion confined to the lamina propria) has near-zero metastatic potential in the colorectum and should be reported as high-grade dysplasia (not carcinoma) per current guidelines.

### Haggitt Classification (Pedunculated Polyps)

The Haggitt levels describe the depth of invasion in pedunculated polyps: Level 0 is carcinoma in situ (intramucosal, not truly invasive), Level 1 invades the submucosa of the head, Level 2 invades the submucosa of the neck, Level 3 invades the submucosa of the stalk, and Level 4 invades the submucosa below the stalk (equivalent to a sessile polyp).

### Kikuchi Classification (Sessile Polyps)

For sessile polyps, the Kikuchi system divides submucosal invasion into SM1 (upper third), SM2 (middle third), and SM3 (lower third). SM3 invasion carries the highest risk of lymph node metastasis.

### Adverse Features (Indicating Need for Surgical Resection)

Features that indicate a need for surgical resection include a positive or indeterminate margin (less than 1 mm clearance at the cauterized margin), poorly differentiated carcinoma, lymphovascular invasion, high-grade tumor budding, and deep submucosal invasion (SM3 or 1000 micrometers or greater in sessile polyps). When adverse features are present, the risk of lymph node metastasis is 10 to 20 percent. Without adverse features, the risk is less than 1 to 2 percent, and polypectomy alone may be curative.

## Polyposis Syndromes

### Familial Adenomatous Polyposis (FAP)

FAP results from a germline APC mutation and produces more than 100 adenomatous polyps with 100 percent colorectal cancer risk without colectomy. Attenuated FAP produces 10 to 99 adenomas with right-sided predominance and later onset. Associated findings include fundic gland polyps (with dysplasia), desmoid tumors, osteomas, and congenital hypertrophy of the retinal pigment epithelium (CHRPE).

### Lynch Syndrome (Hereditary Nonpolyposis CRC)

Lynch syndrome results from germline mutations in mismatch repair genes (MLH1, MSH2, MSH6, PMS2) or EPCAM deletion. Tumors show MSI-high phenotype with tumor-infiltrating lymphocytes, medullary or mucinous histology, and Crohn-like reaction. Universal screening via immunohistochemistry for MMR proteins on all colorectal cancers is now standard; loss of expression triggers further germline testing.

### Serrated Polyposis Syndrome

WHO criteria require either 5 or more serrated polyps proximal to the sigmoid (with at least 2 being 10 mm or larger) or more than 20 serrated polyps of any size distributed throughout the colon. It carries increased colorectal cancer risk and requires close surveillance. The genetic basis is largely unknown and likely polygenic.

### Peutz-Jeghers Syndrome

This syndrome results from germline STK11/LKB1 mutation and produces hamartomatous polyps with a characteristic arborizing smooth muscle pattern. Mucocutaneous melanotic macules appear on the lips, buccal mucosa, and digits. There is increased risk of both GI and extra-GI malignancies.

### Juvenile Polyposis Syndrome

Germline SMAD4 or BMPR1A mutations produce multiple juvenile polyps characterized by dilated, cystically dilated glands, edematous stroma, and surface erosion. Colorectal cancer risk is increased when multiple polyps are present, though sporadic solitary juvenile polyps have no malignant potential.

<image>A medical illustration comparing the three types of conventional adenomas. Panel A (Tubular adenoma): Low-power view showing a pedunculated polyp with round to oval dysplastic glands arranged in a tubular pattern, high-power inset showing low-grade dysplasia with elongated hyperchromatic pseudostratified nuclei. Panel B (Tubulovillous adenoma): Mixed architecture with both tubular glands and finger-like villous projections. Panel C (Villous adenoma): Predominantly villous architecture with long frond-like projections lined by dysplastic columnar epithelium. Panel D: High-grade dysplasia showing loss of nuclear polarity, cribriform glandular architecture, and back-to-back glands.</image>

<image>A medical illustration of serrated polyps. Panel A (Hyperplastic polyp): Serrated (saw-tooth) luminal profile confined to the upper half of the crypts with a normal-appearing crypt base, small pencillate nuclei. Panel B (Sessile serrated lesion): Serration extending to the crypt base with boot-shaped and L-shaped dilated crypts growing horizontally along the muscularis mucosae, asymmetric proliferation. Panel C (SSL with dysplasia): SSL architecture with a focus of conventional-type dysplasia showing abrupt transition to hyperchromatic pseudostratified nuclei. Panel D (Traditional serrated adenoma): Protuberant polyp with distinctive eosinophilic cells, slit-like serration, and ectopic crypt foci (ECF) budding laterally from the main crypts, highlighted by an arrow.</image>

<image>A medical illustration of a malignant polyp showing adverse histologic features. Panel A: Low-power view of a pedunculated polyp with invasive adenocarcinoma extending from the head through the stalk into the submucosa below the stalk (Haggitt level 4). Panel B: High-power view showing poorly differentiated carcinoma cells with lymphovascular invasion, tumor cells visible within a thin-walled lymphatic channel. Panel C: Tumor budding at the invasive front showing single cells and small clusters (<5 cells) of tumor cells at the advancing edge of the carcinoma. Panel D: Cauterized margin assessment showing carcinoma extending to within less than 1 mm of the diathermy margin, considered a positive margin.</image>

## Clinical Pearls

Sessile serrated lesions are the most underdiagnosed polyp type because their flat morphology makes endoscopic detection difficult and their key histologic features (basal crypt dilation, horizontal growth) are subtle. Importantly, one architecturally abnormal crypt is sufficient for diagnosis under current WHO criteria. Intramucosal carcinoma in the colorectum has near-zero metastatic risk and should be reported as "high-grade dysplasia" or "intramucosal carcinoma (noninvasive)" rather than simply "carcinoma," to avoid triggering unnecessary surgical resection at this stage.

When evaluating a malignant polyp, the four critical features to report are margin status, differentiation grade, lymphovascular invasion, and tumor budding. The absence of all adverse features allows conservative management with polypectomy alone. Universal MMR/MSI testing on all colorectal cancers is now standard of care for Lynch syndrome screening; loss of MLH1/PMS2 should prompt BRAF V600E testing or MLH1 promoter methylation analysis to distinguish sporadic (methylated) from Lynch-associated tumors. Traditional serrated adenomas are the rarest serrated polyp but are often misdiagnosed as tubulovillous adenomas; the eosinophilic pencillate cells and ectopic crypt foci serve as distinguishing features.

## References
- WHO Classification of Tumours Editorial Board. *WHO Classification of Tumours: Digestive System Tumours*. 5th ed. IARC; 2019.
- Rex DK, et al. Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. *Gastroenterology*. 2017;153(1):307-323.
- Pai RK, et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology. *Am J Clin Pathol*. 2021;156(3):311-326.
- Chetty R, et al. Serrated polyps of the colorectum. *World J Gastroenterol*. 2016;22(33):7446-7457.
- Vogelstein B, et al. Genetic alterations during colorectal-tumor development. *N Engl J Med*. 1988;319(9):525-532.